摘要
评价临床路径管理在慢性阻塞性肺疾病急性加重期(AECOPD)的应用效果。通过采用回顾性调查,比较进入临床路径(路径组)和没有进入临床路径(对照组)两组患者在住院费用、住院时间及治疗效果3项指标上的差别。结果显示实施临床路径患者(路径组)的平均住院费用、平均住院日等指标均有不同程度的下降,而治愈率有所上升。从而得出临床路径在AECOPD病种的应用能够规范医疗行为,提高医疗护理质量的结论。
To evaklate the application effect of clinical pathway on chronic obstructive pulmonary disease m acute exacerbation stage （AECOPD）. Retrospective study was used to compare the differences between control group and clinical pathway group. The main indexes included： The medical expenses, length of stay and treatment effect. Compared with the control group, both the average medical expenses and length of stay of the clinical pathway group are decreased, but the cure rate was increased. Application of clinical pathway can standardize the medical behavior and improve the quality of
出处
《医学与哲学（B）》
2013年第11期36-39,共4页
Medicine & Philosophy(B)
关键词
临床路径
慢性阻塞性肺疾病急性加重期
效果评价
clinical pathway
chronic obstructive pulmonary disease in acute exacerbation stage
application effect
